My $5k bullish growth play: 3 exciting ASX stocks I just bought for retirement

ملخص مفصل

I’m excited by what these stocks could achieve in the future. The post My $5k bullish growth play: 3 exciting ASX stocks I just bought for retirement appeared first on The Motley…

I'm steadily building my wealth towards retirement and I'm backing some ASX stocks to help me build a significant nest egg.

In my view, the companies that could deliver the best returns are the ones that could deliver the most earnings growth or deliver growth for the longest. Compounding is a very powerful financial force when given time to play out.

If a business made $100 million of revenue last year and grows its revenue by 10%, it becomes $110 million, a rise of $10 million. Another year of 10% revenue growth becomes $121 million, a rise of $11 million. Another year of 10% revenue growth becomes $133.1 million, a rise of $12.1 million.

You can see how as time goes on, compounding makes the dollar amount grow at a faster pace, even when it's growing in the same pace in percentage terms.

When I was thinking recently where to invest $5,000, I was attracted to growth plays that have plenty of earnings compounding ahead of them. With that in mind, I decided to invest around $5,000 across three ASX growth stock names after their share prices dipped, which I'll run through below.

Pro Medicus is a leading provider of medical imaging software and services to hospitals, imaging centres, and healthcare groups globally, with a particular focus on the US.

Its offering includes a suite of radiology imaging solutions, picture archiving and communication systems (PACS), artificial intelligence (AI), and e-health solutions.

When a company is revolutionising an industry, I think one of the key signs of success of the business is how many customers are signing up and how many are staying when their contracts come up for renewal.

In the FY26 result, which was reported in August, the business noted that it signed 10 new contracts worth a minimum of A$407 million during the financial year, including a 10-year $170 million contract with UC Health Colorado.

مطلع المقال، مقتطف من The Motley Fool Australia. لقراءة المقال كاملًا، افتحه على موقع الناشر.